October 2023

If undiagnosed and untreated, juvenile idiopathic arthritis can cause long-term joint damage and vision loss. Biologic drugs have shown to substantially improve outcomes for patients, particularly in the setting of multidisciplinary care.

Heart failure with preserved ejection fraction (HFpEF) is a highly heterogeneous disease associated with comorbidities and mortality. Sodium-glucose cotransporter-2 inhibitors are now recommended for all patients with HFpEF without contraindications. Patient phenotype profiling of contributing comorbidities can help in tailoring management.

Avoidant/restrictive food intake disorder is a relatively new diagnosis that presents a unique set of challenges in terms of understanding, diagnosing and effectively managing abnormal eating behaviours. GPs play an important role in co-ordinating the care and support of affected individuals.